Literature DB >> 12093839

Oocyte and embryo quality after coasting: the experience from oocyte donation.

V Isaza1, J A García-Velasco, M Aragonés, J Remohí, C Simón, A Pellicer.   

Abstract

BACKGROUND: Oocyte donation provides us with an opportunity to study the clinical outcome of oocytes, retrieved from women undergoing coasting, in recipients in whom endometrial receptivity is unaltered by the coasting procedure. Thus, our aim was to describe oocyte donation outcome in donors undergoing coasting, the oocyte and embryo quality obtained from these cycles, and to determine the influence of coasting duration in the cycle outcome.
METHODS: Matched-paired analysis included 15 oocyte donors with high response to ovarian stimulation and submitted to coasting and 15 oocyte donors with normal response to ovarian stimulation and not undergoing coasting. There were 38 oocyte recipients who shared oocytes from the donors under coasting and 37 from donors not undergoing coasting.
RESULTS: Both groups of donors were comparable in terms of days and dose of ovarian stimulation, oocytes retrieved, metaphase II oocytes obtained, and in the appearance of ovarian hyperstimulation syndrome. Both groups of oocyte recipients were comparable in male-associated factor, pregnancy and implantation rates, as well as in embryo quality. Recipients from donors with coasting for >4 days had significantly lower implantation and pregnancy rates.
CONCLUSIONS: the outcome of oocyte donation from donors undergoing coasting is not impaired, as good implantation and pregnancy rates are achieved. Embryo quality, according to our current standards, does not seem to be compromised by coasting itself. However, if coasting in oocyte donors is prolonged for >4 days there is a significant decrease in both implantation and pregnancy rates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093839     DOI: 10.1093/humrep/17.7.1777

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

1.  Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Authors:  Yu-Hung Lin; Kok-Min Seow; Bih-Chwen Hsieh; Lee-Wen Huang; Heng-Ju Chen; Shih-Chia Huang; Chih-Yu Chen; Pei-Hsin Chen; Jiann-Loung Hwang; Chi-Ruey Tzeng
Journal:  J Assist Reprod Genet       Date:  2007-07-17       Impact factor: 3.412

2.  Is Coasting Valuable in All Patients with Any Cause of Infertility?

Authors:  Tahereh Madani; Nadia Jahangiri; Poopak Eftekhari-Yazdi; Mahnaz Ashrafi; Mohammadreza Akhoond
Journal:  Oman Med J       Date:  2016-11

3.  Serum Oestradiol Pattern during Coasting is Different in Antagonist Cycles Compared with Long Agonist Cycles in In Vitro Fertilisation.

Authors:  Koray Elter; Tijen Alev Ozay; Elif Ergin; Murat Hakan Ozörnek
Journal:  Balkan Med J       Date:  2013-12-01       Impact factor: 2.021

4.  GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes.

Authors:  Micah J Hill; Rebecca J Chason; Mark D Payson; James H Segars; John M Csokmay
Journal:  Reprod Biomed Online       Date:  2012-05-23       Impact factor: 3.828

5.  Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?

Authors:  Ömer Hamid Yumuşak; Serkan Kahyaoğlu; Ayşe Seval Özgü Erdinç; Saynur Yılmaz; Yaprak Engin Üstün; Nafiye Yılmaz
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.